Cargando…
Structural Optimization of Polymeric Carriers to Enhance the Immunostimulatory Activity of Molecularly Defined RIG-I Agonists
[Image: see text] RNA ligands of retinoic acid-inducible gene I (RIG-I) hold significant promise as antiviral agents, vaccine adjuvants, and cancer immunotherapeutics, but their efficacy is hindered by inefficient intracellular delivery to the cytosol where RIG-I is localized. Here, we address this...
Autores principales: | Jacobson, Max E., Becker, Kyle W., Palmer, Christian R., Pastora, Lucinda E., Fletcher, R. Brock, Collins, Kathryn A., Fedorova, Olga, Duvall, Craig L., Pyle, Anna M., Wilson, John. T. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2020
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7706089/ https://www.ncbi.nlm.nih.gov/pubmed/33274278 http://dx.doi.org/10.1021/acscentsci.0c00568 |
Ejemplares similares
-
Intratumoral delivery of RIG-I agonist SLR14 induces robust antitumor responses
por: Jiang, Xiaodong, et al.
Publicado: (2019) -
Defining the functional determinants for RNA surveillance by RIG-I
por: Kohlway, Andrew, et al.
Publicado: (2013) -
The Thermodynamic Basis for Viral RNA Detection by the RIG-I Innate Immune Sensor
por: Vela, Adriana, et al.
Publicado: (2012) -
RIG-I activating immunostimulatory RNA boosts the efficacy of anticancer vaccines and synergizes with immune checkpoint blockade
por: Heidegger, Simon, et al.
Publicado: (2019) -
The E3 ligase Riplet promotes RIG-I signaling independent of RIG-I oligomerization
por: Wang, Wenshuai, et al.
Publicado: (2023)